These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 19111417)
1. [Metallo-beta-lactamases producing Pseudomonas aeruginosa in Algeria]. Aggoune-Khinache N; Bensersa D; Henniche FZ; Daoudi M; Abdouni MA; Chabani A; Tiouit D; Naim M Med Mal Infect; 2009 Jun; 39(6):413-4. PubMed ID: 19111417 [No Abstract] [Full Text] [Related]
2. Novel variant (bla(VIM-11)) of the metallo-{beta}-lactamase bla(VIM) family in a GES-1 extended-spectrum-{beta}-lactamase-producing Pseudomonas aeruginosa clinical isolate in Argentina. Pasteran F; Faccone D; Petroni A; Rapoport M; Galas M; Vázquez M; Procopio A Antimicrob Agents Chemother; 2005 Jan; 49(1):474-5. PubMed ID: 15616342 [No Abstract] [Full Text] [Related]
3. First report of the carbapenem-resistant Pseudomonas aeruginosa producing IMP-7 metallo-beta-lactamase in Slovakia. Ohlasova D; Kmet V; Niks M Int J Antimicrob Agents; 2007 Oct; 30(4):370-1. PubMed ID: 17709230 [No Abstract] [Full Text] [Related]
4. Outbreak of Pseudomonas aeruginosa producing IMP-9-type metallo-beta-lactamase in Guangzhou, China. Chao Z; Xiao-Feng W; Dan-Hong S; Jin-Ping Y; Nan-Shan Z Int J Antimicrob Agents; 2008 Oct; 32(4):363-5. PubMed ID: 18619819 [No Abstract] [Full Text] [Related]
5. Detection of VIM-5 metallo-beta-lactamase in a Pseudomonas aeruginosa clinical isolate from Turkey. Bahar G; Mazzariol A; Koncan R; Mert A; Fontana R; Rossolini GM; Cornaglia G J Antimicrob Chemother; 2004 Jul; 54(1):282-3. PubMed ID: 15190017 [No Abstract] [Full Text] [Related]
6. Metallo beta lactamases in Pseudomonas aeruginosa and Acinetobacter species. Gupta V Expert Opin Investig Drugs; 2008 Feb; 17(2):131-43. PubMed ID: 18230049 [TBL] [Abstract][Full Text] [Related]
7. IMP-1 metallo-beta-lactamase-producing Pseudomonas aeruginosa in a university hospital in the People's Republic of China. Wang CX; Mi ZH J Antimicrob Chemother; 2004 Dec; 54(6):1159-60. PubMed ID: 15537691 [No Abstract] [Full Text] [Related]
8. First occurrence of a Pseudomonas aeruginosa isolate in the United States producing an IMP metallo-beta-lactamase, IMP-18. Hanson ND; Hossain A; Buck L; Moland ES; Thomson KS Antimicrob Agents Chemother; 2006 Jun; 50(6):2272-3. PubMed ID: 16723605 [No Abstract] [Full Text] [Related]
17. [Antibiotic susceptibility and occurrence of ESBL, IBL and MBL in Pseudomonas aeruginosa strains]. Wolska K; Jakubczak A; Soszyńska A Med Dosw Mikrobiol; 2008; 60(2):111-9. PubMed ID: 18819447 [TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of phenotypic tests for identification of metallo beta-lactamases producing clinical isolates of Pseudomonas aeruginosa. Singh SP; Shariff M; Barua T; Thukral SS Indian J Med Res; 2009 Jun; 129(6):713-5. PubMed ID: 19692755 [No Abstract] [Full Text] [Related]
19. In vitro and in vivo potency of polymyxin B against IMP-type metallo-beta-lactamase-producing Pseudomonas aeruginosa. Miyajima Y; Hiramatsu K; Mizukami E; Morinaga R; Ishii H; Shirai R; Kishi K; Tokimatsu I; Saikawa T; Kadota J Int J Antimicrob Agents; 2008 Nov; 32(5):437-40. PubMed ID: 18715759 [TBL] [Abstract][Full Text] [Related]
20. EDTA susceptibility leading to false detection of metallo-beta-lactamase in Pseudomonas aeruginosa by Etest and an imipenem-EDTA disk method. Chu YW; Cheung TK; Ngan JY; Kam KM Int J Antimicrob Agents; 2005 Oct; 26(4):340-1. PubMed ID: 16139483 [No Abstract] [Full Text] [Related] [Next] [New Search]